• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

FDA seeks comments on insect repellent-sunscreens


The FDA is seeking information to formulate a regulatory position on insect repellent products that contain OTC sunscreen ingredients. The agency is considering amending its monograph for OTC sunscreen drug products to add conditions for marketing insect repellent-sunscreen drug products. The insect repellent ingredients in these products are regulated by the EPA. Currently there are about 20 combination insect repellent-sunscreen drug products available for consumers. Written comments may be submitted by May 23 to

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.